<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT2014102719707N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2014-11-23</date_registration>
      <primary_sponsor>Vice Chancellor for Research, Qazvin University of Medical Sciences</primary_sponsor>
      <public_title>Effect of Anti-Constipation Belt on patients with chronic constipation</public_title>
      <acronym></acronym>
      <scientific_title>Survey the effect of Anti-Constipation Belt  on patients with chronic constipation</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2014-07-23</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>30</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/17559</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Other design features: Randomization method between control and intervention group is based on the time of their 1st visit. It means that in first month, all of the qualified patients categorize in intervention group, then other patients in their 1st visit categorize in control group.</study_design>
      <phase>0 (exploratory trials)</phase>
      <hc_freetext>chronic constipation.</hc_freetext>
      <i_freetext>Intervention 1: intervention group, members will be treated by massage with Anti-Constipation belt in addition to osmotic laxative. Massage therapy is about 8 sessions in average every 3.5 days. Every session will take about 20 minutes.The GSRS ( gasterointestinal symptoms rating scale) questionnaire will be filled  For every patient to follow their symptoms improvement in the 1st and 4th and 8th visits during the massage sessions and one month after the end of the massage. Intervention 2: members of control group only will receive osmotic laxatives during this study and the  GSRS (gasterointestinal symptoms rating scale) questionnaire will be filled for every patient   to follow their symptoms improvement in 1st visit and then in 4th week and 8th week.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan></results_IPD_plan>
      <results_IPD_description></results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Dr. Arash Miroliaee</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Bouali-sina Hospital, Bouali-sina Street,</address>
        <city>Qazvin,</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip></zip>
        <telephone>+98 28 3333 2930</telephone>
        <email>arash_mir53@yahoo.com</email>
        <affiliation>Qazvin University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Delaram Nahid</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shahid Bahonar Boulevard,</address>
        <city>Qazvin,</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip></zip>
        <telephone>+98 912 238 2160</telephone>
        <email>delaramnahid@yahoo.com</email>
        <affiliation>Qazvin University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Inclusion criteria: Constipation in accordance with RomeII  criteria; constipation dependent on laxatives.  &#13;
Exclusion criteria: Known intestinal cancer; recently undergone abdominal surgery ( 6  month ago) ; pregnancy; dementia diagnosis; diabetes; hypothyroidism; cardiovascular and cerebrovascular disease; major depression disorder; abdominal hernia; severe back pain.</inclusion_criteria>
      <agemin>20 years</agemin>
      <agemax>80 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria></exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>K92.9</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Disease of digestive system, unspecified</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>intervention group, members will be treated by massage with Anti-Constipation belt in addition to osmotic laxative. Massage therapy is about 8 sessions in average every 3.5 days. Every session will take about 20 minutes.The GSRS ( gasterointestinal symptoms rating scale) questionnaire will be filled  For every patient to follow their symptoms improvement in the 1st and 4th and 8th visits during the massage sessions and one month after the end of the massage.</i_keyword>
      <i_keyword>members of control group only will receive osmotic laxatives during this study and the  GSRS (gasterointestinal symptoms rating scale) questionnaire will be filled for every patient   to follow their symptoms improvement in 1st visit and then in 4th week and 8th week.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Constipation. Timepoint: 1st and 4th and 8th visits during the massage session and a month after last session. Method of measurement: GSRS questionnaire ( before, during and after of the massage session ).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Diarrhea. Timepoint: 1st and 4th and 8th visits during the massage session and a month after last session. Method of measurement: GSRS questonnaire ( before, during and after the massage session ).</sec_outcome>
      <sec_outcome>Bloated Abdomen. Timepoint: 1st and 4th and 8th visits during the massage session and a month after last session. Method of measurement: GSRS questonnaire ( before, during and after the massage session ).</sec_outcome>
      <sec_outcome>Gas Passage. Timepoint: 1st and 4th and 8th visits during the massage session and a month after last session. Method of measurement: GSRS questonnaire ( before, during and after the massage session ).</sec_outcome>
      <sec_outcome>Incompelete Defecation. Timepoint: 1st and 4th and 8th visits during the massage session and a month after last session. Method of measurement: GSRS questonnaire ( before, during and after the massage session ).</sec_outcome>
      <sec_outcome>Hard stools defecation. Timepoint: 1st and 4th and 8th visits during the massage session and a month after last session. Method of measurement: GSRS questonnaire ( before, during and after the massage session ).</sec_outcome>
      <sec_outcome>Loose stools defecation. Timepoint: 1st and 4th and 8th visits during the massage session and a month after last session. Method of measurement: GSRS questonnaire ( before, during and after the massage session ).</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Vice Chancellor for Research, Qazvin University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2014-07-22</approval_date>
        <contact_name>Ethics Committee of Qazvin University of Medical Sciences</contact_name>
        <contact_address>Shahid Bahonar Boulevard, Qazvin,  Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
